After two months on the market on May 3, the company gradually fell from the top spot on the shenzhen stock exchange. 

 

As of April 27, the total market value of shunfeng holdings fell to 207.887 billion yuan, after 218.34 billion yuan in the group of 220.92 million and vanke A. 

 

Since May 2016 backdoor listing plan was released, suitable abundant holdings has attracted many attentions of the capital market, the stock price after the bell up, until the total market value "ding" become the first in shenzhen. Motion founder wang wei's personal wealth surged 278.57%, with a net worth of $15.9 billion to become the bete noir of the Forbes rich list, more than li and gou, Chinese rich list ranked seventh. 

 

Capital markets are largely supported by the fundamentals of the company. The company's 2016 operating performance continued to lead the Chinese express industry, with revenue exceeding 57 billion yuan, while net profit jumped by more than 250 percent to 26.43 billion yuan. 

 

The growth of the Chinese Internet economy is a miracle of growth. In motion a strengthening in China's express delivery industry status, the cold chain system branch Courier "into" pharmaceutical logistics industry, the impact the already facing reshuffle of medicine circulation industry. 

 

Shandong illegal vaccine case let the medicine circulation industry officials noted that China is not a can override the national pharmaceutical cold-chain transport enterprise, the motion of wang wei to see unlimited business opportunities, and with its huge distribution network to explore this high-end logistics market. 

 

"Now, more and more strict regulation of the industry, the implementation of the two votes and a vote, make the drug circulation structure changes, there are a lot of new model need some resources and a new solution to fall to the ground, I think the future of the market is very good and suitable abundant opportunities." On April 27, ma jiancong, assistant director of the cold transportation division of the company, said in an exclusive interview with The Times weekly. 

 

At present, the motion in the pharmaceutical cold-chain logistics industry layout, the layout of the case, what is the future development path, industry how to think of such a new "into" "barbarians"? 

 

Cut into medical logistics 

 

For now, it is 2014 that the company has entered the pharmaceutical logistics industry. This year, the company's revenue exceeded 38 billion yuan, and wang wei set up the medical logistics department alone. But little is known about this, and the logistics of the pharmaceutical industry are unknown in the industry. 

 

Two years later, the shandong illegal vaccine incident became a key point in the logistics of pharmaceutical logistics. "Shandong vaccine after the events, the industry is in reflect, can't find can override the cold-chain transport enterprises, after see this kind of business opportunities, motion as a super express enterprise, want to cut into the medicine logistics in this industry." On April 27th, the first anniversary of the shandong vaccine trial, senior Chinese medical professionals said to The Times. 

 

In shandong province after the outbreak of the illegal vaccine case, the state council revised the regulations on the administration of the circulation of vaccines and vaccination, clear to strict management of circulation of vaccines, resolutely put a stop to illegal operations by borrow qualification and notes of "affiliated walking ticket" behavior, and to establish a traceability system in the whole process of the vaccine from production to use, strengthen the storage, transportation, cold chain requirements, add CDC, vaccination units in the receiving link for the obligations of temperature monitoring and recording. 

 

In the internal motion Ma Jiancong traders do pharmaceutical cold-chain transportation, has a more profound experience on the change of national policy, "now in terms of the policy environment, medicine circulation of two votes, vaccines, one vote, regulatory requirements, indeed in this one or two years to be the resulting medicine demand of cold chain". 

 

Previously, the domestic pharmaceutical cold-chain logistics common single distribution network, information capacity is low and so on, at the same time, environmental monitoring technology lag behind, lack of real-time monitoring, real-time query and temperature of the cold chain traceability technology, pharmaceutical cold-chain logistics industry faces many non-standard place. 

 

In addition, due to the lack of professional refrigeration pharmaceutical cold-chain logistics enterprises in our country, the serious shortage of professional cold car carrier number, as well as the existing cold transport vehicle cooling technology lack of normative, but also highlights the pharmaceutical products high transportation requirements and cold chain logistics present situation, the contradiction between medical cold chain logistics enterprises to high standards, standardization of the equipment into the cold. 

 

And from their own, Ma Jiancong thinks, motion as express leading enterprises, with the current national regulatory requirements for medical logistics transportation "match", "transportation requirements of the pharmaceutical industry, the service customer types including downstream of the hospital, the centers for disease control and prevention, etc., in the logistics industry is the high side, has nothing to do with suitable abundant resources, the management system and quality requirements." 

 

In addition, Ma Jiancong tells a reporter, motion in terms of logistics tracking and traceability is more outstanding, "more layers of traceability requirements, conform to the state and enterprises of every link of the gun scan, and the general logistics company and medicine circulation enterprises, no such resource and operation ability." 

 

It is with these foundation, the sustained power of motion on the pharmaceutical cold-chain logistics, previously don't know suitable abundant medicine cold transport business, until May 2016 the issue of the backdoor listing plan was disclosed. 

 

According to the plan, the controlling motion of transport business mainly focused on the food fresh and cold medicine logistics two fields, mainly in the face of seasonal agricultural products vendors, as well as the pharmaceutical production enterprise, medicine, electricity and other customer. 

 

"Original medicine circulation is hierarchy distribution, the enterprise has its own logistics, every level again, look for outsourcing logistics to complete now flattening is equal to the supply chain, with the policy requirements and market changes, if there are determined to do this thing well, present and future opportunities than ever before, a reshuffle of opportunities here." "Mr Ma told The Times. 

 

Network of fronts 

 

In march this year, the motion controlling released 2016 annual report, released its in medicine cold transport business scale, the final report, cold transport network covering 26 cities and surrounding areas, there are two medicine, cold storage, 12 medicine mains, well versed in the northeast, north China, east China, south China, central China core cities. 

 

In addition, the medical cold storage area of medicine and the operation area of the center is 25,000 square meters, 497 of the refrigerated truck, which according to the GSP requires the vehicle 227. Current business covering food, medicine, industry of service production, electricity, distribution, retail, and other fields, the pharmaceutical industry customers are: Harbin pharmaceutical, sanofi, medicine, mindray, etc. 

 

If, before the case of the backdoor listing, the distribution in the healthcare sector was a small, fast run, it was a quick march after a successful listing. With its capital strength and operating base, it has accelerated its layout in the medical and cold chain system. 

 

"Pharmaceutical companies directly face the various provinces and cities of the country's downstream customers, it now needs to do more than the national warehouse, often finish after long positions in the whole country, will draw from its production enterprise to the warehouses, and then to transport around the warehouse to the same company to do it." 'so the strategy of the overall development of shunfeng is to build a warehouse,' Mr. Ma said. 

 

According to ma, the pharmaceutical warehouse in shunfeng is now in guangzhou and chengdu, and nanjing should be in use around June this year. With the warehouse, we can solve the problem of multi-warehouse customers. 

 

In addition, the second step, motion in December last year made a national network of drug front north from Harbin, south to guangzhou, to the west of chengdu, is in the east Shanghai, nanjing. 

 

According to verify time weekly reporter, at present there is a medical unit, its motion is located in guangzhou yuexiu district, namely suitable abundant pharmaceutical supply chain co., LTD. (hereinafter referred to as "along abundant medicine"), its business scope includes third-party drugs modern logistics business (entrusted drug production enterprise storage distribution drugs, special control except drugs). 

 

According to the industrial and commercial data, the registered capital of shunfeng pharmaceutical is 50 million yuan, which was established on July 29, 2015, and the legal representative is tang yi, the President of the department of cold transportation of shun feng. 

 

Reporters noted that the industrial and commercial data shows, in June 2016 and August, suitable abundant medicine, foreign invested in two companies respectively along abundant pharmaceutical supply chain co., LTD., nanjing (hereinafter referred to as "the medicine of nanjing" motion) and the pharmaceutical supply chain motion (heilongjiang) co., LTD. (hereinafter referred to as "along abundant pharmaceutical heilongjiang"), the legal representative of the two companies are all Tang Yi. 

 

Reporter discovery, in chengdu, southwest along abundant also have great abundant pharmaceutical co., LTD., a subsidiary of chengdu its registered capital is 15 million yuan, the legal representative for Tang Yi still. 

 

In the construction of the southwest and south China, east China and north China subsidiary after four regions, suitable abundant frequent contact with the local pharmaceutical companies, and to cooperate with them. 

 

The reporter learns from motion, they are to provide integrated solutions for some big enterprises, such as Harbin pharmaceutical group, at its will now all plant (drug) transport in the hands of the motion. 

 

"In the past it to logistics supplier, but many are subcontracting, for example, if you gave A today, it went to A line, A province to B to walk the line, after B answered no distribution in local resources, and transferred to C, these past are faced with this situation." Mr. Ma told The Times that he saw where my car was based on an order. 

 

Advantage is that all the resources are their own motion, distribution of ground this can realize control themselves, so that the whole time, safety, traceability can be customer satisfaction. 

 

In addition, shunfeng began shipping cities in some provinces, and now it is in guangdong. "The distribution of thousands of pharmacies at the drugstore business is basically what we're going to do." That's what the company said. 

 

In addition, the business of the pharmaceutical e-commerce company, shunfeng is also exploring the idea. In recent years, the development of medical electrical business rapidly, suitable abundant hope with their own quality management system, to manage the corresponding resources, ensure to complete the operation according to drug management specification, "we are also trying to do, this aspect is still need to perfect constantly." "He told The Times. 

 

Soft power builds will take time 

 

In recent years, shunfeng's layout in the field of medical logistics has kept the industry on the sidelines. 

 

This year on February 22, the motion controlling backdoor listing of the bell the day before yesterday, the China federation of logistics and purchasing medicine logistics branch in 2017, President of dasheng suitable abundant headquarters in shenzhen, China federation of logistics and purchasing vice President and secretary general Cui Zhong pay, the chief executive wang wei motion on the meeting. 

 

All on the same day, large domestic pharmaceutical circulation enterprises send someone to attend, from kyushu, medicine, prescription, CRC, tasly, Kant's music, people f medical apparatus and instruments, Beijing Greg, Chinese health peak, prosperous time, yunnan HaoBang, tianjin, guangdong sig letter hon, hunan sunward, yuantong express, shaanxi send Leon companies such as representatives to attend the meeting. 

 

Time weekly reporter noted that the delegates discussed in six aspects, and puts forward some industry hotspot difficult problems, such as drug delivery vehicles into the city traffic problems, drug traceability coding, pharmaceutical logistics facilities equipment validation issues, insurance problem of cold chain products, etc. 

 

A large circulation enterprises in charge of pharmaceutical cold-chain logistics of domestic people, said in an interview with time weekly reporter pharmaceutical cold-chain logistics industry now is the environment opportunities and challenges coexist, "the state of cold chain attaches great importance to this, there are a lot of supporting policies, have such a file. Challenge problem is that there is no one enterprise, really can do the nation". 

 

In the industry point of view, the current motion mode, or in the main line to attract the attention of the outside world, "this is very easy to set up main line, in the short term to let everyone see effect, can quickly build city channel, but the short-term results of main line, not to evaluate they already have cold chain comprehensive service ability." 

 

It is understood that the medicine main motion transportation network covering 26 major cities in China at present, regional distribution to cover major cities around 26 200 km range area, basic covers more than 75% in key areas across the country. The company has 39 all-cargo aircraft and will provide aviation support for the medical supply chain. 

 

There are domestic senior medical cold chain system insiders told reporters, the time weekly motion into pharmaceutical logistics industry, grasp the business opportunities very accurate, but face a big problem is the construction of soft power, distribution system and sent a member of the original, a commission from the company, how many express it, how much income can be completed, "but the service of medical institutions is completely different with ordinary service customers, medical institution has its own shipping requirements, and more demanding than conventional express many". 

 

Hardware is easy to make, these people said, like a warehouse, vehicles, but in personnel and have corresponding operation management system construction aspect, these are not a day two days can form, it requires a long running-in process. 

 

That is a challenge for the company. In third party logistics actively into the pharmaceutical circulation at the same time, the original medicine circulation industry giants are not idle, characters, such as medicine, kyushu circulation giants are accelerated at the grassroots the stationing, with "the last kilometer" of drug circulation. 

 

These giants are structures, more sophisticated marketing network, the implementation of effective coverage at the grassroots level to give priority to with suitable abundant, third party logistics enterprise is very challenging. 

 

And motion in the backdoor listing, list their competitors in the field of medicine, "the main rival in the field of medicine cold transport including the pass international freight agency (Shanghai) co., LTD., Shanghai springs of the cold chain logistics co., LTD., TNT and so on enterprise."